Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity
19751.1k citationsRonald B. Herberman, Myrthel E. Nunn et al.International Journal of Cancerprofile →
Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells
1975660 citationsRonald B. Herberman, Myrthel E. Nunn et al.International Journal of Cancerprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by David H. Lavrin
Since
Specialization
Citations
This map shows the geographic impact of David H. Lavrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Lavrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Lavrin more than expected).
This network shows the impact of papers produced by David H. Lavrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Lavrin. The network helps show where David H. Lavrin may publish in the future.
Co-authorship network of co-authors of David H. Lavrin
This figure shows the co-authorship network connecting the top 25 collaborators of David H. Lavrin.
A scholar is included among the top collaborators of David H. Lavrin based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with David H. Lavrin. David H. Lavrin is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Bellino, Francis L., Raymond A. Daynes, Peter J. Hornsby, David H. Lavrin, & John E. Nestler. (1995). Dehydroepiandrosterone (DHEA) and aging. New York Academy of Sciences eBooks.31 indexed citations
Herberman, Ronald B., Myrthel E. Nunn, & David H. Lavrin. (1975). Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. International Journal of Cancer. 16(2). 216–229.1064 indexed citations breakdown →
5.
Herberman, Ronald B., Myrthel E. Nunn, Howard T. Holden, & David H. Lavrin. (1975). Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. International Journal of Cancer. 16(2). 230–239.660 indexed citations breakdown →
Lavrin, David H., Steven A. Rosenberg, Robert Connor, & William D. Terry. (1973). Immunoprophylaxis of methylcholanthrene-induced tumors in mice with Bacillus Calmette-Guérin and methanol-extracted residue.. PubMed. 33(3). 472–7.27 indexed citations
12.
Ting, Chou‐Chik, David H. Lavrin, Kenneth K. Takemoto, Robert C. Ting, & Ronald B. Herberman. (1972). Expression of various tumor-specific antigens in polyoma virus-induced tumors.. PubMed. 32(1). 1–6.22 indexed citations
Lavrin, David H.. (1970). Immunology of spontaneous mammary carcinomas in mice: immunogenicity of mammary tumor virus-contaning tissues in mammary tumor virus-free C3H-2 hosts.. PubMed. 30(4). 1156–62.4 indexed citations
15.
Lavrin, David H., Phyllis B. Blair, & David Weiss. (1966). Immunology of Spontaneous Mammary Carcinomas in Mice. Cancer Research. 26(5). 293–304.66 indexed citations
16.
Blair, Phyllis B., et al.. (1966). Immunology of the mouse mammary tumor virus (MTV) : identification in vitro of mouse antibodies against MTV.. PubMed. 26(4). 647–51.23 indexed citations
17.
Lavrin, David H., Phyllis B. Blair, & David Weiss. (1966). Immunology of spontaneous mammary carcinomas in mice. 3. Immunogenicity of C3H preneoplastic hyperplastic alveolar nodules in C3Hf hosts.. PubMed. 26(2). 293–304.20 indexed citations
18.
Lavrin, David H., Phyllis B. Blair, & David Weiss. (1966). Immunology of spontaneous mammary carcinomas in mice IV. Association of the mammary tumor virus with the immunogenicity of C3H nodules and tumors.. PubMed. 26(5). 929–34.29 indexed citations
19.
Lavrin, David H., M Dezfulian, & David Weiss. (1965). The antigen responsible for acquired resistance to spontaneous mammary carcinomas in mice. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory).1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.